Webinar: The future of clinical trials
22 de enero | 3-4 pm.
The randomized controlled trial is the gold standard when it comes to developing new drugs, but it's expensive, time-consuming, and, in some cases, not even possible. So, with encouragement from the FDA, the drug industry is advancing efforts to modernize clinical trials, streamlining the process of figuring out whether a treatment actually works.
Join STAT on Jan. 22 as we delve into new approaches, examine case studies, and better understand the future of clinical trials.